Nabriva Therapeutics PLC - ADR (NBRV) Up 3.88% in Premarket Trading

Monday, November 15, 2021 07:20 AM | InvestorsObserver Analysts

Mentioned in this article

Nabriva Therapeutics PLC - ADR (NBRV) Up 3.88% in Premarket Trading

Nabriva Therapeutics PLC - ADR (NBRV) has gained Monday morning, with the stock increasing 3.88% in pre-market trading to 1.07. NBRV's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 141 out of 146 industries, Nabriva Therapeutics PLC - ADR ranks higher than 0% of stocks. Nabriva Therapeutics PLC - ADR has fallen 12.71% over the past month, closing at $1.21 on October 18. During this period of time, the stock fell as low as $1.03 and as high as $1.40. NBRV has an average analyst recommendation of Buy. The company has an average price target of $2.68.

NBRV has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on NBRV!

See Full NBRV Report

Nabriva Therapeutics PLC - ADR has a Long-Term Technical rank of 4. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 96% of the market scoring higher. In the Biotechnology industry which is number 141 by this metric, NBRV ranks better than 13% of stocks.

Important Dates for Investors in NBRV:

-Nabriva Therapeutics PLC - ADR is set to release earnings on 2/7/2022. During their last earnings release the company posted EPS of $-2.73. -We do not have a set dividend date for Nabriva Therapeutics PLC - ADR at this time. Click Here To Get The Full Report on Nabriva Therapeutics PLC - ADR (NBRV)